Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
53.85
+10.24 (23.48%)
At close: Apr 28, 2026, 4:00 PM EDT
53.85
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:28 PM EDT
KNSA Employees
Kiniksa Pharmaceuticals International, had 366 employees as of December 31, 2025. The number of employees increased by 51 or 16.19% compared to the previous year.
Employees
366
Change (1Y)
51
Growth (1Y)
16.19%
Revenue / Employee
$1,851,268
Profits / Employee
$161,216
Market Cap
4.14B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,796 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 778 |
KNSA News
- 8 hours ago - Kiniksa Pharmaceuticals International, Earnings Call Transcript: Q1 2026 - Transcripts
- 9 hours ago - Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 5 days ago - Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 - GlobeNewsWire
- 7 days ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Month - Benzinga
- 20 days ago - Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals International, Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals International, Earnings Call Transcript: Q4 2025 - Transcripts